![]() | |
![]() | |
| www.criteriuminc.comDECEMBER 2009 | |
This Month's Clinical Focus: Cardiology
"We found that men still have a higher prevalence than women, but what has happened is that the gap has narrowed," said Dr. Amytis Towfighi, assistant professor of clinical neurology at the University of Southern California, lead author of one of two reports in the Oct. 26 issue of Archives of Internal Medicine. "For women it has increased, for men it has decreased."
The narrowing of the male-female difference is easily explained, Towfighi stated. "Very basically, the risk factors are being better controlled in men than in women." In men, levels of "bad" LDL cholesterol remained the same between the two surveys, while levels of "good" HDL cholesterol improved. Blood pressure levels improved, and fewer men smoked. The improvements for women were marginal, with LDL cholesterol levels about the same. The only risk factor that improved in women was HDL cholesterol. Diabetes and obesity increased in men and women, the study found. "We don't know exactly what is going on in terms of
risk factors being better controlled. Women aren't checked as often,"
Towfighi acknowledged. Societal changes
may play a role, she said. With more women in
the work force, she said, their rising rates of obesity and diabetes can
be attributed to job demands that limit their ability to exercise and
follow dietary rules. It is no longer assumed that female hormones protect against heart disease, she said. Doctors are paying more attention to heart risk factors in women because "there is a red flag about women not being absolutely protected against heart disease in midlife, as we had thought, and we are aware that more effort must be made to reduce their risk," Towfighi said.
"Perhaps physicians are paying more attention to the detection and treatment of women with heart disease," Vaccarino said. "It could be the same thing happening in the general public, with women getting more knowledgeable about this." "Basically, both studies show that there still is a
gap between men and women," said Dr. Nieca Goldberg, clinical associate
professor of medicine at NYU Langone Medical Center and a spokeswoman for
the American Heart Association. "They both show the importance of
continuing to pay attention to women's risk of cardiovascular disease and
treatment of their heart attacks."
(SOURCES: Amytis Towfighi, M.D., assistant professor of clinical neurology, University of Southern California, Los Angeles; Viola Vaccarino, M.D., Ph.D., professor, medicine, director, Emory Program in Cardiovascular Outcomes Research and Epidemiology, Atlanta; Nieca Goldberg, M.D., clinical associate professor of medicine, NYU Langone Medical Center, New York City; Oct 26, 2009 Archives of Internal Medicine)
Study:
"Typically, when a patient presents with chest pain and the (SPECT) test result is normal, we tell them everything looks fine, but this may not be the case," Dr. John Mahmarian of the Methodist DeBakey Heart and Vascular Center in Texas, who led the study, said in a statement. He said if a large amount of calcified plaque is found on artery walls -- something that can't be seen in SPECT imaging -- the patient has a high long-term risk of having a heart attack or stroke. "Based on our findings, using both tests to define risk is better than either test alone," Mahmarian said in a statement.
They said people with a normal SPECT who have other risk factors that put them at risk for heart trouble -- such as smoking, high cholesterol, high blood pressure, diabetes or a family history of heart trouble -- would benefit from the extra test. "We're not recommending doing this to everybody. The patient has to have clinical risks," Dr. Su Min Chang of the Methodist Hospital, who worked on the study, said in a telephone interview.
The team did not look at whether the two-test strategy is cost effective but they said such studies are needed. Imaging tests are a major source of escalating health costs and curbing excessive use of such tests is a major target of health reform in the United States. (Source: Reuters Health, Nov. 2 2009) Change your workflow paradigm to transform your
clinical trials into rapid, results-oriented studies. Criterium knows resources are precious, time is
the enemy, and results are paramount. Our user-friendly technologies
improve the efficiencies of all our clinical development services. Our
talented, in-house staff is committed to the professional support of our
clients needs. Get To Know Us! We have several propriety technology solutions available that are proven to improve your clinical trial results. Contact John Hudak at jmhudak@criteriuminc.com
|
|
| About
Criterium Inc. (www.criteriuminc.com) is a global,
full-service, and technology-driven contract research organization that
offers a unique mix of high-quality, innovative clinical research
solutions for the biopharmaceutical, pharmaceutical, medical device, and
CRO industries.
GET TO KNOW US! | |
| This email was sent by Criterium Inc.com. You are receiving this email because of your affiliation with Criterium Inc. If you do not wish to receive Criterium Inc. announcements and updates, please unsubscribe here. If the link is not working, please send an e-mail to releases@criteriuminc.com and type "UNSUBSCRIBE" in the subject line or please send a letter including your name, request for removal, and e-mail address to: Criterium Inc., 358 Broadway, Suite 201, Saratoga Springs, NY 12866. | |
![]() | |